Publication Date: 2024/01/16
Abstract: Hairy cell leukemia variant (HCLv) / Splenic B cell-lymphoma/leukemia with prominent nucleoli (SBLPN) is a more aggressive disease, refractory to standard therapy. Molecular evaluation does not reveal BRAFp.V600E mutation unlike classic HCL.
Keywords: Hairy Cell Leukemia, Splenic B Cell- Lymphoma/Leukemia with Prominent Nucleoli, Hclv, BRAF.
DOI: https://doi.org/10.5281/zenodo.10518143
PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT24JAN625.pdf
REFERENCES